Jeffrey S Gonzalez1, Erica Shreck2, Christina Psaros3, Steven A Safren3. 1. Ferkauf Graduate School of Psychology and Diabetes Research Center, Albert Einstein College of Medicine, Yeshiva University. 2. Ferkauf Graduate School of Psychology, Yeshiva University. 3. Behavioral Medicine Service, Department of Psychiatry, Massachusetts General Hospital.
Abstract
OBJECTIVE: To better understand independent pathways linking emotional distress, medication adherence, and glycemic control in adults with Type 2 diabetes, as well as the potential mediating effects of perceived control over illness and self-efficacy. METHOD: Adults with Type 2 diabetes (N = 142) were recruited for an intervention study evaluating cognitive-behavioral therapy for adherence and depression. Depressive symptom severity was assessed via semistructured interview. Validated self-reports assessed diabetes-related distress, perceived control over diabetes (perceived control), self-efficacy for diabetes self-management, and medication adherence. Glycemic control was evaluated by hemoglobin A1C. Only baseline data were included in correlational and linear regression analyses. RESULTS: Perceived control was an important mediator of emotional distress for both medication adherence and A1C outcomes. Specifically, regression analyses demonstrated that diabetes distress, but not depression severity, was significantly related to medication adherence and A1C. Self-efficacy and perceived control were also independently associated with medication adherence and A1C. Mediation analyses demonstrated a significant indirect effect for diabetes distress and medication adherence through perceived control and self-efficacy. The relationship between distress and A1C was accounted for by an indirect effect through perceived control. CONCLUSION: Results demonstrated that diabetes-related emotional distress is associated with poorer treatment adherence and glycemic control among adults with Type 2 diabetes; these relationships were partially mediated through perceived control over diabetes. Perceptions of one's personal ability to influence the course of diabetes may be important in understanding the pathway between emotional distress and poor diabetes-treatment outcomes. (c) 2015 APA, all rights reserved).
OBJECTIVE: To better understand independent pathways linking emotional distress, medication adherence, and glycemic control in adults with Type 2 diabetes, as well as the potential mediating effects of perceived control over illness and self-efficacy. METHOD: Adults with Type 2 diabetes (N = 142) were recruited for an intervention study evaluating cognitive-behavioral therapy for adherence and depression. Depressive symptom severity was assessed via semistructured interview. Validated self-reports assessed diabetes-related distress, perceived control over diabetes (perceived control), self-efficacy for diabetes self-management, and medication adherence. Glycemic control was evaluated by hemoglobin A1C. Only baseline data were included in correlational and linear regression analyses. RESULTS: Perceived control was an important mediator of emotional distress for both medication adherence and A1C outcomes. Specifically, regression analyses demonstrated that diabetes distress, but not depression severity, was significantly related to medication adherence and A1C. Self-efficacy and perceived control were also independently associated with medication adherence and A1C. Mediation analyses demonstrated a significant indirect effect for diabetes distress and medication adherence through perceived control and self-efficacy. The relationship between distress and A1C was accounted for by an indirect effect through perceived control. CONCLUSION: Results demonstrated that diabetes-related emotional distress is associated with poorer treatment adherence and glycemic control among adults with Type 2 diabetes; these relationships were partially mediated through perceived control over diabetes. Perceptions of one's personal ability to influence the course of diabetes may be important in understanding the pathway between emotional distress and poor diabetes-treatment outcomes. (c) 2015 APA, all rights reserved).
Authors: W H Polonsky; B J Anderson; P A Lohrer; G Welch; A M Jacobson; J E Aponte; C E Schwartz Journal: Diabetes Care Date: 1995-06 Impact factor: 19.112
Authors: William P Sacco; Kristen J Wells; Andrea Friedman; Rebecca Matthew; Sylvia Perez; Christine A Vaughan Journal: Health Psychol Date: 2007-11 Impact factor: 4.267
Authors: Sarah Stark Casagrande; Nilka Ríos Burrows; Linda S Geiss; Kathleen E Bainbridge; Judith E Fradkin; Catherine C Cowie Journal: Diabetes Care Date: 2012-04-12 Impact factor: 19.112
Authors: Lawrence Fisher; Danielle Hessler; Russell E Glasgow; Patricia A Arean; Umesh Masharani; Diana Naranjo; Lisa A Strycker Journal: Diabetes Care Date: 2013-06-04 Impact factor: 19.112
Authors: Christina N Massey; Emily H Feig; Laura Duque-Serrano; Deborah Wexler; Judith Tedlie Moskowitz; Jeff C Huffman Journal: Diabetes Res Clin Pract Date: 2018-11-27 Impact factor: 5.602
Authors: Christina M DuBois; Rachel A Millstein; Christopher M Celano; Deborah J Wexler; Jeff C Huffman Journal: Prim Care Companion CNS Disord Date: 2016-05-05
Authors: Jeffrey S Gonzalez; Naomi S Kane; Deborah H Binko; Amit Shapira; Claire J Hoogendoorn Journal: Diabetes Care Date: 2016-10-17 Impact factor: 19.112
Authors: Julie Silverman; James Krieger; Meghan Kiefer; Paul Hebert; June Robinson; Karin Nelson Journal: J Gen Intern Med Date: 2015-04-28 Impact factor: 5.128